Characterization of ocular pharmacokinetics of tilisolol after instillation into anesthetized rabbits

Biological and Pharmaceutical Bulletin

Volumn 22, Issue 11, 1999, Pages 1253-1255

  Sasaki, Hitoshi ^a   Yamamura, Kenzo ^b   Mukai, Takahiro ^b   Nishida, Koyo ^b   Nakamura, Junzo ^b   Nakashima, Mikiro ^a   Ichikawa, Masataka ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Diffusion model; Drug delivery system; Ocular penetration; Ocular pharmacokinetics; Tear deficiency; Tilisolol

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PENTOBARBITAL; TILISOLOL;

ANIMAL EXPERIMENT; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DIFFUSION; DRUG DISPOSITION; DRUG ELIMINATION; DRUG INSTILLATION; DRUG PENETRATION; EYE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; LACRIMAL FLUID LEVEL; LACRIMATION; MALE; MATHEMATICAL MODEL; NONHUMAN; RABBIT;

EID: 0033404907     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.22.1253     Document Type: Article

References (11)

1. Schoenwald R. D., Clin. Pharmacokinet., 18, 255-269 (1990).
2. Lee V. H. L., Robinson J. R., J. Pharm. Sci., 68, 673-684 (1979).
3. Lee V. H. L., Robinson J. R., J. Ocul. Pharmacol., 2, 67-108 (1986).
4. Sasaki H., Yamamura K., Nishida K., Nakamura J., Ichikawa M., Prog. Ret. Eye Res., 15, 583-620 (1996).
5. Chrai S. S., Patton T. F., Mehta A., Robinson J. R., J. Pharm. Sci., 62, 1112-1121 (1973).
6. Patton T. F., Robinson J. R., J. Pharm. Sci., 64, 1312-1316 (1975).
7. Patton T. F., Robinson J. R., J. Pharm. Sci., 65, 1295-1301 (1976).
8. Yamamura K., Sasaki H., Nakashima M., Ichikawa M., Mukai T., Nishida K., Nakamura J., Pharm. Res., 16, 1596-1601 (1999).
9. Yano Y., Yamaoka K., Tanaka H., Chem. Pharm. Bull., 37, 1035-1038 (1989).
10. Nakagawa Y., Sugai T., Chin W.-P., Shibuya T., Hashimoto K., Imai S., Arzneim.-forsch./Drug Res., 34, 194-199 (1984).
11. Tadokoro Y., Sato K., Hatakeyama S., Kawase S., Japan. Patent 255618 (1990).